Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Howard Safran, MD
Brown University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Rush-Presbyterian-St. Luke'S Medical Center
Chicago, Illinois, United States
- New England Medical Center Hospital
Boston, Massachusetts, United States
- St. Elizabeth'S Medical Center
Boston, Massachusetts, United States
- Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Mount Sinai Medical Center, Ny
New York, New York, United States
- University of Pittsburgh Cancer Institute
Pittsburgh, Pennsylvania, United States
- Memorial Hospital of Rhode Island
Pawtucket, Rhode Island, United States
- Brown University Oncology Group
Providence, Rhode Island, United States
- Rhode Island Hospital
Providence, Rhode Island, United States
- Roger Williams Medical Center/busm
Providence, Rhode Island, United States
- University of Texas - Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 1999
- Primary completion
- —
- Completion
- —
- Last update posted
- 19 Dec 2013
- Registered enrollment
- 41
- Registry id
- NCT00003797
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.